These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16167526)

  • 1. Chronic relapsing thrombotic thrombocytopenic purpura successfully treated with rituximab: case report.
    Gianfaldoni G; Antonioli E; Mannelli F; Vannucchi AM; Bosi A
    J Chemother; 2005 Aug; 17(4):449-51. PubMed ID: 16167526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
    Patino W; Sarode R
    J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S
    Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
    Clark WF; Rock G; Barth D; Arnold DM; Webert KE; Yenson PR; Kelton JG; Li L; Foley SR;
    Br J Haematol; 2015 Jul; 170(2):208-17. PubMed ID: 25855259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rituximab for managing refractory thrombotic thrombocytopenic purpura: a report of three cases].
    Yamanouchi J; Hato T; Miyoshi K; Kobayashi S; Azuma T; Hasegawa H; Yasukawa M
    Rinsho Ketsueki; 2013 Feb; 54(2):205-9. PubMed ID: 23470828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
    Chemnitz JM; Uener J; Hallek M; Scheid C
    Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
    Bhagirath VC; Kelton JG; Moore J; Arnold DM
    Transfusion; 2012 Dec; 52(12):2517-23. PubMed ID: 22486316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of rituximab therapy for refractory/relapsing thrombotic thrombocytopenic purpura].
    Cui J; Zhu TN; Zou N; Chen M; Zhao YQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):116-20. PubMed ID: 23469801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab.
    Caramazza D; Quintini G; Abbene I; Malato A; Saccullo G; Lo Coco L; Di Trapani R; Palazzolo R; Barone R; Mazzola G; Rizzo S; Ragonese P; Aridon P; Abbadessa V; Siragusa S
    Transfusion; 2010 Dec; 50(12):2753-60. PubMed ID: 20576013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Hong H; Aoyama Y; Yamamura R; Ohta T; Mugitani A; Yamane T; Hino M; Matsumoto M; Fujimura Y
    Rinsho Ketsueki; 2006 Dec; 47(12):1528-32. PubMed ID: 17233471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child.
    Jayabose S; Dunbar J; Nowicki TS; Tugal O; Ozkaynak MF; Sandoval C
    Pediatr Hematol Oncol; 2011 Mar; 28(2):167-72. PubMed ID: 20469972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse.
    Westwood JP; Webster H; McGuckin S; McDonald V; Machin SJ; Scully M
    J Thromb Haemost; 2013 Mar; 11(3):481-90. PubMed ID: 23279219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.
    Ling HT; Field JJ; Blinder MA
    Am J Hematol; 2009 Jul; 84(7):418-21. PubMed ID: 19507208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
    Rubia J; Moscardó F; Gómez MJ; Guardia R; Rodríguez P; Sebrango A; Zamora C; Debén G; Goterris R; López R; Peña F; Pujol M; Vidaller A; Río-Garma JD; Sanz MA;
    Transfus Apher Sci; 2010 Dec; 43(3):299-303. PubMed ID: 20934383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab as prophylaxis in chronic relapsing thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Montoya RC; Poiesz BJ
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):338-41. PubMed ID: 22498981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with rituximab in a patient with TTP secondary to severe ANCA-associated vasculitis.
    Asamiya Y; Moriyama T; Takano M; Iwasaki C; Kimura K; Ando Y; Aoki A; Kikuchi K; Takei T; Uchida K; Nitta K
    Intern Med; 2010; 49(15):1587-91. PubMed ID: 20686295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paediatric case report of an acquired autoimmune thrombotic thrombocytopenic purpura].
    Curtillet C; Poullin P; Doré E; Fossat C; Lefevre P; Michel G
    Arch Pediatr; 2006 Dec; 13(12):1521-4. PubMed ID: 17010579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab.
    Sankararaman S; Jeroudi M; Ibrahim H
    Pediatr Int; 2014 Dec; 56(6):914-918. PubMed ID: 25521977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: report of four cases.
    Pequeño-Luévano M; Villarreal-Martínez L; Jaime-Pérez JC; Gómez-de-León A; Cantú-Rodríguez OG; González-Llano O; Gómez-Almaguer D
    Hematology; 2013 Jul; 18(4):233-6. PubMed ID: 23432850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.